Review
Open access
Oct 2026
Multiple Myeloma Measurable Residual Disease: Spotting Three Different Detection Methods
Current evidence suggests that combining marrow-based and blood-based assays may identify residual disease most accurately, and a combined approach has not yet been validated prospectively, and for now it should be used within clinical trials.
S. Tartaglione, M. Tagliaferro, M. C. Scerpa et al.
· International Journal of Mol... · 0 citations